161.12 0.00 (0.00%)
After hours: 4:15PM EDT
|Bid||161.62 x 800|
|Ask||161.64 x 800|
|Day's Range||159.25 - 162.87|
|52 Week Range||108.85 - 177.99|
|Beta (5Y Monthly)||0.50|
|PE Ratio (TTM)||45.73|
|Forward Dividend & Yield||1.56 (0.97%)|
|Ex-Dividend Date||May 13, 2020|
|1y Target Est||N/A|
ResMed and Rugby League Hall of Famer and head coach Brad Fittler are teaming up to raise Australians' awareness of the importance of healthy sleep.
Propeller Health's digital sensor and app for AstraZeneca's Symbicort inhaler has received 510(k) clearance from the U.S. FDA.
Over 140 long-term care facility and home-based care employees recognized for commitment to patient and resident safety during the COVID-19 pandemic.
ResMed MaskSelector is here, a digital tool to make remote patient CPAP mask selection and sizing easier and more effective.
ResMed President and COO Rob Douglas will participate in a virtual fireside chat at the Bank of America Securities Healthcare Conference 2020.
ResMed’s AirView platform helps clinicians remotely monitor and advise ventilator and bilevel device patients safer by reducing in-person visits.
Asthma-related symptoms, E.R. visits and hospitalizations all decreased, according to data from Propeller Health inhaler sensors and local hospitals.
ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2020 on Thursday, April 30, 2020, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this call.
NEW YORK, Feb. 13, 2020 -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, is investigating certain officers and directors of Zuora, Inc. (NYSE:.
Waud Capital Partners (Waud Capital), a leading growth-oriented middle market private equity firm, today announced that it has entered into an executive partnership agreement with John Damgaard to acquire companies and assets to build a leading Healthcare Information Technology (HCIT) software platform. Mr. Damgaard is a highly successful software executive and HCIT leader with more than 25 years of management experience. Waud Capital has a long history of partnering with management leaders to build platforms in healthcare and technology markets. Waud Capital has committed $150 million of equity capital to the partnership with Mr. Damgaard.
WeissLaw LLP, a national class action and shareholders' rights law firm with offices in New York, California and Georgia, announces an investigation of ResMed Inc. (NYSE: RMD) ("ResMed," or the "Company").
NEW YORK, NY / ACCESSWIRE / January, 21, 2020 / Levi & Korsinsky announces it has commenced an investigation of ResMed Inc. (NYSE:RMD) concerning possible breaches of fiduciary duty. To obtain additional ...
Globus Medical, Inc. (GMED), a leading musculoskeletal solutions company, today announced the appointment of Robert Douglas to the Company’s Board of Directors, and the departure of Board member Kurt Wheeler, effective December 11, 2019. Mr. Wheeler has assumed a role that precludes him from serving on public company Boards. Mr. Douglas has nearly thirty years of experience in medical device technology, with particular expertise in digital health.
Cerner Corporation (CERN), a global health platform and innovation company, and ResMed (NYSE: RMD, ASX: RMD), a world-leading digital health company, today announced a new collaboration agreement to help providers make more informed treatment decisions, control costs and deliver seamless care across health systems to the home. To address this trend, Cerner designated ResMed’s Brightree Home Health and Hospice platform as its preferred solution in the space to integrate with its Cerner Millennium® electronic health record (EHR).